6 completed, 2 recruiting, 1 not yet recruiting. 4 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 2 |
Follow Keratoderma, Palmoplantar, Epidermolytic: new trials by email Literature Review of Keratoderma, Palmoplantar, Epidermolytic trials Research Report on Keratoderma, Palmoplantar, Epidermolytic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Instrumental Assessment of Plantar Hyperkeratosis in Healthy Subjects and Patients With Diabetes Instrumental Assessment of Plantar Hyperkeratosis - Diabetes Mellitus, Hyperkeratosis | Not applicable | Not yet recruiting | University of Seville | 50 | 2026-02-01 | 2026-02-17 |
| Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ STRATICYTE™ Test - Mouth Diseases | Recruiting | Proteocyte Diagnostics Inc. | 180 | 2023-01-01 | 2024-11-07 | |
| A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin Investigational Skin Preparation Device, GMDN 47102 / Electrode Skin Abrasive Pad, UMDNS 13-230 / Biopsy punch (Dermal Curette) - Keratosis, Actinic, Actinic Lesion | Not applicable | Completed | Mirka Ltd | 26 | 2022-09-01 | 2023-10-10 |
| Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Completed | LMC Diabetes & Endocrinology Ltd. | 5084 | 2020-03-03 | 2021-02-25 | |
| Ultrasonographic Evaluation of Cosmetic Keratolytic Treatment of Foot Calluses and Corns Topical Keratolytic Cosmetic (Serum + Cream) - Hyperkeratosis, Callus | Not applicable | Completed | Wroclaw University of Health and Sport Sciences | 124 | 2020-02-01 | 2026-08-14 |
| The CO2RE® System for Vulvar Lichen Sclerosus The CO2RE® System - Vulvar Lichen Sclerosus | Not applicable | Completed | Candela Corporation | 14 | 2018-07-11 | 2022-03-22 |
| Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment Standard of Care Histopathology, STRATICYTE Assessment - Oral Neoplasm | Recruiting | Proteocyte Diagnostics Inc. | 500 | 2015-03-12 | 2024-11-07 | |
| Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 604 | 2011-02-01 | 2019-04-03 |
| Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail AN2690 Topical Solution, 5%, Solution Vehicle - Onychomycosis of Toenails | Phase 3 | Completed | Pfizer | 594 | 2010-12-01 | 2019-02-22 |
Foot Dermatoses (3) · Leukoplakia (3) · Nails, Malformed (3) · Onychomycosis (3) · Diabetes Mellitus (2) · Disease (2) · Erythroplasia (2) · Hyperplasia (2) · Onycholysis (2) · Twenty-Nail Dystrophy (2) · Yellow Nail Syndrome (2) · Callosities (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Keratoderma, Palmoplantar (9) · Keratoderma, Palmoplantar, Diffuse (9) · Keratosis (9) · Skin Diseases (9) · Skin Diseases, Genetic (9) · Skin and Connective Tissue Diseases (9) · Pathological Conditions, Anatomical (6) · Pathological Conditions, Signs and Symptoms (6) · Neoplasms (4) · Precancerous Conditions (4) · Bacterial Infections and Mycoses (3) · Dermatomycoses (3) · Foot Diseases (3)
Solutions (2)
Pfizer (2) · Proteocyte Diagnostics Inc. (2) · Candela Corporation (1) · LMC Diabetes & Endocrinology Ltd. (1) · Mirka Ltd (1) · University of Seville (1) · Wroclaw University of Health and Sport Sciences (1)
United States (4) · Canada (3) · Finland (1) · Poland (1)
Johanna H Hagman, M.D, PhD (1) · Konika P Schallen, MD (1) · Mark Darling, MSc, MChD (1) · Ronnie Aronson, MD (1) · Simon W Young, DDS, MD, PhD (1)